Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of N-acetylcysteine on Parkinson's disease
IRCT20181006041247N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in Parkinson's disease (PD), sponsored by Kurdistan University of Medical Sciences. Started Apr 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on IRCT20181006041247N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181006041247N1.